Metraipolis › archive › dc_9675dc8d8bf8
Safety, tolerability, pharmacokinetics, and pharmacodynamics of LW402, a preferential Janus kinase 1 inhibitor in healthy volunteers: a randomized,… — Europe PMC PMID:42137333
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42137333
- DOI
- 10.3389/fphar.2026.1784350
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T02:08:48.676Z
- SHA-256 of the archived text
90fd0f7e871009cebc367c8944d9b4912c0634d67c889cef9d2c5e3c691edc74- Stable URL of this page
https://metraipolis.com/documento/dc_9675dc8d8bf8
How to cite
Safety, tolerability, pharmacokinetics, and pharmacodynamics of LW402, a preferential Janus kinase 1 inhibitor in healthy volunteers: a randomized,… — Europe PMC PMID:42137333 — Europe PMC (en), https://europepmc.org/article/MED/42137333 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9675dc8d8bf8 (Metraipolis archive dc_9675dc8d8bf8, sha256 90fd0f7e871009cebc367c8944d9b4912c0634d67c889cef9d2c5e3c691edc74)
BibTeX
@misc{dc9675dc8d8bf8,
title = {Safety, tolerability, pharmacokinetics, and pharmacodynamics of LW402, a preferential Janus kinase 1 inhibitor in healthy volunteers: a randomized,… — Europe PMC PMID:42137333},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42137333},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9675dc8d8bf8; sha256 90fd0f7e871009cebc367c8944d9b4912c0634d67c889cef9d2c5e3c691edc74},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42137333. Agents can read the archived copy with the MCP tool read_document.